Results 21 to 30 of about 296,701 (305)

Safety and efficacy of enterprise stenting for symptomatic atherosclerotic severe posterior circulation stenosis

open access: yesEuropean Journal of Medical Research, 2023
Purpose To investigate the safety and efficacy of Enterprise stent angioplasty and risk factors for the prognoses in treating symptomatic severe posterior circulation atherosclerotic stenosis (SSPCAS).
Zhi-Long Zhou   +8 more
doaj   +1 more source

Stent-in-Stent Endovascular Correction in Right Internal Carotid Artery Restenosis: a Clinical Case

open access: yesКреативная хирургия и онкология, 2021
Background. Carotid artery restenosis is a rare complication of carotid stenting. The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) reveals an in-stent restenosis rate of 0–6 %, a fairly low value given an extensive study ...
T. N. Khafizov   +6 more
doaj   +1 more source

Imaging in-stent restenosis: an inexpensive, reliable, and rapid preclinical model. [PDF]

open access: yes, 2009
Preclinical models of restenosis are essential to unravel the pathophysiological processes that lead to in-stent restenosis and to optimize existing and future drug-eluting stents. A variety of antibodies and transgenic and knockout strains are available
Deuse, Tobias   +3 more
core   +2 more sources

Spectral Photon-Counting Computed Tomography for Coronary Stent Imaging: Evaluation of the Potential Clinical Impact for the Delineation of In-Stent Restenosis.

open access: yesInvestigative Radiology, 2020
OBJECTIVES In-stent restenosis (ISR) is one of the main long-term complications after coronary stent placement, and the ability to evaluate ISR noninvasively using coronary computed tomography (CT) angiography remains challenging.
G. Bratke   +9 more
semanticscholar   +1 more source

Iron corroded granules inhibiting vascular smooth muscle cell proliferation

open access: yesMaterials Today Bio, 2022
In-stent restenosis after interventional therapy remains a severe clinical complication. Current evidence indicates that neointimal hyperplasia induced by vascular smooth muscle cell (VSMC) proliferation is a major cause of restenosis.
Dongxu Qiu   +9 more
doaj   +1 more source

Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries [PDF]

open access: yes, 2011
<p><b>Objective:</b> We have previously demonstrated that bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs), is effective in reducing neointimal formation in rodent models of vascular injury by reducing smooth ...
Baker, A.H.   +10 more
core   +1 more source

A polymer coated cicaprost-eluting stent increases neointima formation and impairs vessel function in the rabbit iliac artery [PDF]

open access: yes, 2016
Drug-eluting stents have been successful in reducing in-stent restenosis but are not suitable for all lesion types and have been implicated in causing late stent thrombosis due to incomplete regeneration of the endothelial cell layer.
Jones, Robert L.   +4 more
core   +2 more sources

The Mechanisms of Restenosis and Relevance to Next Generation Stent Design

open access: yesBiomolecules, 2022
Stents are lifesaving mechanical devices that re-establish essential blood flow to the coronary circulation after significant vessel occlusion due to coronary vessel disease or thrombolytic blockade.
Jessie Clare   +5 more
semanticscholar   +1 more source

IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)

open access: yesPakistan Armed Forces Medical Journal, 2020
Objective: To study the frequency of In-Stent Restenosis and its treatment in patients undergoing Percutaneous Coronary Intervention for coronary artery disease. Study Design: Descriptive cross sectional study.
Waseem Raja   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy